Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccine.
Agrati C, Castilletti C, Goletti D, Sacchi A, Bordoni V, Mariotti D, Notari S, Matusali G, Meschi S, Petrone L, Aiello A, Najafi Fard S, Farroni C, Colavita F, Lapa D, Leone S, Agresta A, Capobianchi M, Ippolito G, Vaia F, Puro V; INMI COVID-19 Vaccine Study Group.
Agrati C, et al. Among authors: petrone l.
Sci Rep. 2022 Apr 23;12(1):6687. doi: 10.1038/s41598-022-07741-z.
Sci Rep. 2022.
PMID: 35461335
Free PMC article.